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Background: Legislations and international organizations provide a framework to ensure proper risk
assessment of Genetically Modiﬁed Organisms (GMO). With regard to the deliberate release of GMO as
food or feed, applications for Genetically Modiﬁed Plants (GMP) typically contain data for the molecular
characterisation at the nucleic acid level based on Southern blot and polymerase chain reaction analysis
in combination with Sanger sequencing. Along with the diverse range of applications of next-generation
sequencing (NGS) in genomic research, some recent research projects and product developers explored
the use of NGS as an alternative tool for meeting the data requirements for the molecular characteri-
sation of GMPs in view of their risk assessment.
Scope and approach: By means of a literature survey and information collected through the organisation
of an international workshop, we investigated whether NGS can replace and/or complement the
currently used techniques for molecular characterisation of GMP taking into account the possibilities
and current bottlenecks of NGS technologies and recent developments in molecular breeding.
Key ﬁndings and conclusions: We conclude that although NGS might present clear advantages for product
developers, NGS currently does not always offer a signiﬁcant added value with respect to the risk
assessment of GMPs. However, the approaches used so far may soon be further challenged by the fast
evolution in NGS technologies and also by the recent developments in molecular breeding of plants. We
postulate that setting up a common workﬂow for the generation of relevant and interpretable data by
NGS would facilitate a scientiﬁcally sound assessment of GMPs.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Several legislations and international organizations provide a
framework to ensure proper risk assessment (RA) of Genetically
Modiﬁed Organisms (GMO) with respect to their possible impact
on human/animal health and environment. With regard to the(K. Pauwels), Sigrid.
r), Adinda.DeSchrijver@wiv-
. du Jardin), Nancy.roosens@
p.be (P. Herman).
Ltd. This is an open access article udeliberate use of GMO as food or feed, for which new applications
in Europe and other parts of the world mainly concerns GM plants
(GMP) so far, the aim is to investigate whether the genetic modi-
ﬁcation could inadvertently increase the potential toxicity or
allergenicity of the recipient plant, and alter its nutritional quality.
Molecular characterisation of the GMP is required to get insight into
the genomic locus/loci of modiﬁcation, the potential impact on the
function of the interrupted endogenous genes (e.g. by gene
disruption) or the generation of new open reading frames (ORF) at
the site(s) of insertion. In the European Union (EU), molecular
characterisation data not only serve RA, they are also a prerequisite
for the development of detection and identiﬁcation techniques in
view of the traceability and labelling requirements of GMP prior to
their regulatory approval for release (European Parliament, 2003b).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
K. Pauwels et al. / Trends in Food Science & Technology 45 (2015) 319e326320The latter drives enforcement laboratories to continuously update
tools and technical capacities that could facilitate standardized,
reliable and accurate molecular characterisation on a routine basis
(Broeders, De Keersmaecker, & Roosens, 2012; Holst-Jensen, 2009).
Molecular characterisation data at the nucleic level of GMP serving
the RA are currently obtained by Southern blot (SB) and polymerase
chain reaction (PCR) analysis in combination with Sanger
sequencing approaches to determine the precise location of the
junction between the transgenic insert and the host genome, and to
detect the possible presence of backbone sequences of the trans-
formation vector. Indeed, GMP of the ﬁrst-generation technologies,
are obtained by the introduction of recombinant DNA from or-
ganisms including bacteria and viruses and non-crossable plants,
resulting in non-targeted insertion of a large cassette of foreign
DNA and the creation of junction sequences encompassing one of
the borders of the foreign DNA-insert and the adjacent native plant
DNA-sequence. Recent developments in plant breeding include the
increasing number in stacked events (Kok et al., 2014), the
expanding variety of transformed species and new traits and novel
techniques for genetic modiﬁcation of plants. The latter concern
techniques that enable the introduction of novel traits in a plant
species without the introduction of large sequence of DNA from
non-crossable species, i.e. techniques such as site-directed
nuclease-mediated mutagenesis or oligonucleotide-directed
mutagenesis (SDN-1, SDN-2 or ODM), inducing targeted speciﬁc
changes in the plant genome that only encompass a limited number
of base pairs, thereby showing many similarities with plants ob-
tained by classical mutagenesis. Whether plants obtained by such
site-directed mutagenesis techniques should fall within the scope
of the European GMO regulatory framework is still matter of debate
(Breyer et al., 2009; Hartung & Schiemann, 2014; Heap, 2013;
Pauwels, Podevin, Breyer, Carroll, & Herman, 2014; Podevin,
Devos, Davies, & Nielsen, 2012). However, if regulated, the molec-
ular characterisation requirements by means of currently used
approaches (including SB analysis) could clearly pose challenges.
Some recent publications (Kovalic et al., 2012; Yang et al., 2013)
propose the ongoing advances in DNA-sequencing, the so-called
‘next generation sequencing’ (NGS) or high-throughput
sequencing technologies as an additional, or even replacing, tool
for molecular characterisation of GMP.
The increasing sequencing throughput possibilities, at contin-
uously decreasing costs, combined with the digital nature and the
tuneable resolution of NGS technologies have paved the way for its
implementation in several areas of genomic research and in a
diverse range of applications. In the area of GMP, NGS can facilitate
post-transformation screening during product development by
increasing time effectiveness, scalability and automation in the
selection of potential valuable events on the basis of their molec-
ular proﬁle (Heck et al., 2005). Additionally, compared to SB anal-
ysis, NGS has been reported as an efﬁcient approach to achieve
molecular characterisation of GMP (Kovalic et al., 2012). On the
other hand, the currently used NGS technologies have some limi-
tations, are more expensive than the SB approach and require a
profound expertise in bioinformatics as they are producing a
considerable amount of data that needs to be analysed and
interpreted.
In this viewpoint we aimed at identifying how NGS data could
contribute to themolecular characterisation of GMP in light of their
RA and regulatory approval, but also of plants obtained through
novel directed molecular techniques, and whether NGS has in this
respect an added value as compared to the currently used tech-
niques. To answer this question, several consensus documents is-
sued by FAO, OECD and EFSA were consulted which provide data
requirements for the molecular characterisation of GMP (Devos
et al., 2014; EFSA Panel on Genetically Modiﬁed Organisms(GMO), 2011; Food and Agricultural Organization of the United
Nations [FAO], 2003; FAO, 2008; Organisation for Economic
Cooperation and Development [OECD], 2010). Furthermore, we
used the information gathered during an international workshop
on the use of NGS for the molecular characterisation of GMO that
we organized with attendees from academia, NGS platforms,
companies, GMO laboratories and advisory bodies. The EU regula-
tory framework was used to investigate whether NGS can replace
and/or complement the currently used techniques (European
Commission, 2013), considering the possibilities and bottlenecks
of the present NGS platforms and the potential challenges for
molecular characterisation posed by recent developments in plant
breeding. Although some elements discussed in this viewpoint
might apply to GMO in general, we focused on GMP because a vast
majority of applications submitted under Regulation (EC) No 1829/
2003 in the EU, but also submitted in other parts of the world,
concerns plants, thereby justifying themore urgent need to address
the questions posed in the viewpoint speciﬁcally for plants.
2. Data requirements for the molecular characterisation of
GMP
In the EU, GMP market registration applications for food and/or
feed are submitted under Regulation (EC) No 1829/2003 (European
Parliament, 2003a). EFSA's Scientiﬁc Panel on GMO (GMO Panel)
has developed guidance documents for the preparation and pre-
sentation of such applications (e.g. (EFSA Panel on Genetically
Modiﬁed Organisms (GMO), 2011)). It provides the rationale for
data requirements of the different components of RA and describes
the information needed for the molecular characterisation of GMP.
At the nucleic acid level, the provided information should include
the description of nucleic acids intended for transformation and of
any (vector) sequence that could be potentially inserted to the
recipient plant, and a description of the nucleic acids actually
inserted in the plant, including sub-cellular location, copy number
and sequence. Further, the genetic stability of the insert over
several generations needs to be established as well as the occur-
rence of novel ORFs in the region spanning the inserted DNA and
the native plant DNA (Table 1, ﬁrst column, point i to vii).
Recently, the RA approach for GM food and/or feed detailed in
the EFSA guidance has been incorporated into a legal text, the
Implementing Regulation (IR) (EU) No 503/2013, covering only
applications concerning GM plants for food and feed uses, and
which presents some differences in RA requirements compared
with the former. For example for stacked transformation events,
comparisons of sequences of the inserts and ﬂanking regions
should be carried out between the GMP containing stacked trans-
formation events and their corresponding single events, while the
guidance document only demands to control insert integrity in the
stacked compared to corresponding single events (Table 1, vii). We
used the IR, containing one of the most explicit data requirements
for molecular characterisation of GMP intended for food and feed as
a starting point to explore potential added values of NGS for the
molecular characterisation of GMP compared to currently used
techniques (Table 1).
The currently used techniques to fulﬁl the data requirements for
molecular characterisation at the nucleic acid level are SB analysis,
a technique enabling a speciﬁc restriction fragment to be detected
against a background of many other restriction fragments by using
a probe (Southern, 1975), and PCR analysis in combination with
Sanger sequencing approaches (Table 1, column 2). Up-to-date
databases are used for bioinformatic analysis of the sequence at
the insertion site. When using appropriate controls and probe/re-
striction enzyme combinations providing complete coverage of
sequences that could be inserted into a given plant genome, SB
Table 1
Possibilities and limitations of NGS, compared to conventional approaches, for molecular characterisation of GMP in view of their risk assessment.
EU data requirements for molecular
characterisation (according to IR)a
Covered by current techniques (SB and
Sanger)
Covered by NGS today or in the near
future
Added value of NGS (now or in the near
future) compared to current techniquesb
i) Insert(s)
1) Size and copy number of all detectable
inserts (complete or partial)
2) Absence of vector backbone
Yes, depending on the overlap between
the probe and the hybridised restriction
fragment, the hybridization/washing
stringency conditions and size limitation
(both maximal and minimal) of the
detected fragments
1) Yes: number of junction sequences
(‘chimeric’ sequences) found
2) Yes, if no unintended junction
sequences are detected
Whole genome resequencing: small
inserts will be spotted, standardized
procedure (independent of probes
contrary to target enrichment or SB).
Less starting material (DNA) is required
ii) Sub-cellular location(s) of insert(s) e.g.
nucleus, chloroplast, mitochondria or
maintained in non-integrated form
Not possible with SB only, need for
additional Sanger sequencing
of the ﬂanking regions
Yes, via sequence analysis of the ﬂanking
region
Today: no added value
Near future: increased cost-effectiveness
and streamlined procedure
iii) Organisation and sequence of the
inserted genetic material at each
insertion site
(Also required for stacked events)
Not possible with SB only, need for
additional Sanger sequencing
Today: assembling small read lengths is
challenging. Paired-end sequencing,
longer reads or ‘read walking’ (Wahler
et al., 2013) increases feasibility
Today: Sequencing of insert is possible
but still needs to be conﬁrmed by classic
PCR and Sanger sequencing.
Near future: sequencing of inserts by
deep sequencing and longer sequencing
reads
iv) Sequence information for both 50 and
30 ﬂanking regions at each insertion site
Not possible with SB only, need for
additional Sanger sequencing
Yes Today: no added value
Near future: may be possible by the use
of longer reads
v) Information on creation of ORFs present
within insert and region spanning the
junction site and veriﬁcation of
potential similarities of these ORF with
known toxins or allergens
(bioinformatics analysis)
Not possible with SB only, need for
additional Sanger sequencing
Yes. Might be more efﬁcient via capture.
ORF analysis requests accurate sequence
information
Today: no added value.
Near future: may be possible by the use
of longer reads
vi) Genetic stability of the events Yes, stability is shown when SB pattern is
consistent among all generations studied
Yes, stability is shown when patterns of
detected junction sequence is consistent
among all generations studied
Today: No added value
Near future: increased cost-effectiveness
and streamlined procedure
vii) Stacked events: control of insert
integrity in the stack compared to
corresponding single events and
comparison of sequences of the inserts
and the ﬂanking regions obtained from
GM plants containing single events and
plants containing stacked
transformation events.
Yes, but becomes more cumbersome with
increasing number of inserts, combination
with Sanger sequencing needed
Today sequencing of insert is possible
but still needs to be conﬁrmed by classic
PCR and Sanger sequencing. Near future:
sequencing of inserts by deep
sequencing.
Today: Possible advantage in case of
multiple insertions
Near future: increased cost-effectiveness
for stacks with high number of inserts
owing to universal, high throughput
method combined with standardized
procedures
viii) Information on the expression of the
intended and unintended inserted/
modiﬁed sequences (e.g. data at the
protein, metabolite level and/or RNA
level)
Covered by approaches such as Western
bot, ELISA, Northern blot and methods to
determine metabolites such as liquid and,
gas chromatography, and capillary
electrophoresis. Sanger sequencing of EST
populations is a way to perform
transcriptomic analysis.
Today: For the RNA level*: Yes, RNA-Seq
* NGS is a method involving nucleic
acids, so information at the protein or
metabolite level cannot be directly
measured with this technology
In the future: potential transcriptome
proﬁling, sRNA proﬁling in case of RNAi-
based GMP
a Several consensus documents issued by FAO, OECD and EFSA, were consulted which provide data requirements for the molecular characterisation of GMO (Devos et al.,
2014; EFSA Panel on Genetically Modiﬁed Organisms (GMO), 2011; FAO, 2003; FAO, 2008; OECD, 2010). However, the Implementing Regulation (IR) (EU) No 503/2013 was
taken as source of data requirements to elaborate on the possibilities and limitations of NGS for molecular characterisation of GMP in view of their risk assessment.
b Some of these points have also been discussed during the international workshop on the use of NGS for the molecular characterisation of GMP that we organised.
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number at each insertion site, the genetic elements (e.g. promoters,
enhancers or backbone sequences) inserted and genetic stability
(Table 1, column 2, i and vi). SB analysis is sometimes com-
plemented with real-time PCR (possibly also with digital PCR) to
determine the copy-number of the insert. PCR analysis of the entire
insert as well as of the ﬂanking sequences, combined with Sanger
sequencing, is used to determine the exact DNA-sequence of the
transgenic locus (Table 1, column 2, iii, iv and v). Limitations of SB
include the high amount of input DNA required, multiple manual
work interventions, the use of agarose gels, case speciﬁc use of
restriction enzymes and design of radioactive probes (thereby
already anticipating the results), and the impossibility to clearly
identify a high number of copies, all aspects that may become
cumbersome when dealing with GMP with stacked transformation
events. Also the genetic changes obtained by new molecular
breeding techniques are difﬁcult (impossible) to be characterised
by SB. Recently, NGS has been proposed as an alternative to these
current approaches for molecular characterisation of GMP (Kovalic
et al., 2012; Yang et al., 2013). Another requirement for molecularcharacterisation of GMP is to demonstrate whether the inserted/
modiﬁed sequence results in intended changes at the protein, RNA
or metabolite level (Table 1, column 1, viii). The current approaches
to verify this include Western blot, ELISA, Northern blot and
compositional analysis (e.g. gas liquid chromatography). However,
except for data at the RNA level, NGS does not offer a direct alter-
native to these approaches.
3. Possibilities offered by next-generation sequencing for RA
of GMP
Theoretically, starting from the (complete) genome sequence of
a GMP, the data requirements at the nucleic acid level as set out in
IR (see Table 1) could be collected. However, it is not known to
which extent NGS can accurately deliver this (complete) genome
sequence.
NGS DNA sample preparation involves the shearing of the
genomic DNA, using starting material in lesser quantities than
needed for SB (up to more than 10-fold less), the selection of DNA-
fragments of the appropriate size and the subsequent library
K. Pauwels et al. / Trends in Food Science & Technology 45 (2015) 319e326322construction of DNA-fragments that are sequenced in parallel re-
actions. The obtained strings of bases, called reads, are then aligned
or assembled to theoretically reveal the entire sequence of the DNA
sample. Most interesting is the preparation of a paired-end library,
allowing to sequence both ends of a DNA fragment where the ends
are separated by a known distance. This will result in much better
alignment of the reads, especially across difﬁcult-to-sequence, re-
petitive regions of the genome, which is an important issue for
plant genomes (Imelfort & Edwards, 2009).
Assembly of (a selected set of) the reads can be done bymapping
to a reference sequence, i.e. a known (genome) sequence (refer-
ence-based mapping or re-sequencing). Subsequently, the
sequence of the aligned reads can be subjected to further charac-
terisation. For obtaining molecular characterisation data for RA of
GMP, the applicability of NGS by the reference-based approach has
been demonstrated for a GM soybean (Kovalic et al., 2012) (Table 1, i
column 3). The transformation vector and the reference genome of
the native soybean were used as queries for the selection of reads,
which were then further subjected to bioinformatic analysis in
order to characterise the number and identity of novel ORF ob-
tained upon genetic modiﬁcation. ORF at the junction region (the
so-called junction sequences) were characterised based on the
presence of reads covering both the transformation plasmid
sequence and a sequence likely derived from either the native plant
genome ﬂanking the insertion or either rearranged transformation
plasmid DNA. Further, the backbone portion of the transformation
vector served to reveal whether backbone sequences were intro-
duced into the plant genome during the transformation process. In
the same study, the reference-based approach was also able to
examine a GM soybean event with multiple inserts and rear-
rangements (Kovalic et al., 2012). Another study showed the po-
tential of NGS for the molecular characterisation of GM rice events,
using the sequence of the host reference genome and the plasmid
tomap the reads, thereby revealing an unintended transgene insert
(599 bp) which had not been identiﬁed using the state-of-the-art
SB approach (Yang et al., 2013) (Table 1, i and iii, column 3). It is
important to note that whilst NGS results identiﬁed the presence
and localisation of inserts, and can also sketch a map of the insert
sequence (Yang et al., 2013), the insert sequence was still veriﬁed
and validated by PCR and Sanger sequencing, because with the NGS
analysis, no accurate assembly of the total long insert is possible yet
due to the short sequence reads length (Kovalic et al., 2012; Yang
et al., 2013).
Assembly of reads is also possible in the absence of a reference
sequence (de novo assembly, de novo sequencing). In the ﬁeld of
GMP, only de novo assembly restricted to the region of the insert
sequence has been reported yet (Liang et al., 2014; Wahler,
Schauser, Bendiek, & Grohmann, 2013; Yang et al., 2013). Com-
bined with the appropriate bioinformatic analysis, a de novo as-
sembly limited to the reads not mapping to the host reference
genome sequence could offer interesting opportunities for the
identiﬁcation and characterisation of (un)authorized GMP for
which the insert sequences in the genome are a priori unknown and
thus cannot be used as a query (Liang et al., 2014; Wahler et al.,
2013; Yang et al., 2013). Indeed, research projects related to
detection and identiﬁcation strategies of GMP (both authorized and
unauthorized) currently also explore the use of NGS and appro-
priate bioinformatics for data analysis and hence share similar
approaches and questions with regard to the generation of relevant
NGS data (Liang et al., 2014; Wahler et al., 2013; Yang et al., 2013).
NGS offers the ability for whole genome sequencing. For an
accurate assembly of the complete genome to be technically
possible using currently available sequence assembly tools, sufﬁ-
ciently high sequence coverage and long sequence reads are
needed (Kovalic et al., 2012; Sims, Sudbery, Ilott, Heger, & Ponting,2014). The coverage and length of the sequence reads depend on
the size of the genome, the number of samples included in one
sequencing run, the type of library constructed and the type of NGS
platform used. As elaborated above, the currently used approaches
for NGS data analysis to characterize GMP do not involve complete
genome assembly, given the large genome size of GMP and the
concomitant high cost linked to sequencing the full genome,
although the complete genome is used as input DNA in the
sequence analysis for the identiﬁcation of the insertion loci. A prior
physical enrichment (i.e. capture approach) of the targeted
sequence by speciﬁc capture through probes designed comple-
mentary to the regions of interest has been developed by several
companies as an efﬁcient alternative method for the identiﬁcation
of the insertion loci (Bodi et al., 2013; Hunst, 2013). In the subse-
quent targeted sequencing approach, a library from genomic DNA
of the captured regions only is used as input. One such commer-
cially developed method was recently used to identify T-DNA
insertion sites in Arabidopsis mutants (Lepage, Zampini, Boyle, &
Brisson, 2013). By using the transformation vector sequence as
template to design the probes, the DNA-library was enriched with
fragments containing the insert and junction sequences. Instead of
in silico selection of sequencing reads mapping to the trans-
formation vector (Kovalic et al., 2012), the NGS data are enriched in
reads of the insert and junction sequence. The data will be more
straightforward to interpret, without the need for a reference host
genome sequence. As less reads are used for regions which are not
of interest (native host genome sequence), more samples can be
pooled in one analysis, thereby seriously reducing the cost.
It is important to note that studies using NGS for the molecular
characterisation of GMP so far have only been done on GMP ob-
tained by ﬁrst-generation technologies. It is worth considering the
possibilities offered by NGS technologies in light of the use of novel
plant breeding techniques. NGS has already been applied for the
identiﬁcation of small insertions and deletions (indels) in Arabi-
dopsis thaliana (Cao et al., 2011) and rice (Wahler et al., 2013), so
NGS could potentially offer an advantage compared to SB in terms
of the detection of small sequence modiﬁcations.
NGS also enables transcriptome proﬁling (Chu & Corey, 2012)
and can elucidate potential altered expression proﬁles of genes
ﬂanking the transgene insert (Table 1, viii). It could also inform on
the relative abundance or composition of the pool of small regu-
latory RNAs (siRNA pool) in GMP designed to induce silencing of
target genes (referred as RNAi-based GMP in Fig. 1) (Guo, Li, Wang,
& Liang, 2015). However, some NGS methods determining siRNA
pools are confronted with bias and caution is needed in the inter-
pretation of data for risk assessment purposes (Ramon et al., 2014).
4. Technical bottlenecks of NGS in view of molecular
characterisation of GMP
Despite the advantages of NGS for some of the aspects of mo-
lecular characterisation of GMP, there are also some bottlenecks
linked to the limitations of the currently available NGS technologies
(McGinn & Gut, 2013; van Dijk, Auger, Jaszczyszyn, & Thermes,
2014), for both data production and data analysis (Table 1, col-
umns 3 and 4).
As the NGS technology produces a huge amount of short
sequencing reads, the correct and accurate assembly of these reads
is a prerequisite to use these kind of data for the molecular char-
acterisation of GMP. However, this assembly is subject to the
following technical bottlenecks.
A ﬁrst limitation is related to the small-size reads produced by
the currently available NGS platforms (300 nucleotides), their size
depending on the library and NGS platform used (McGinn & Gut,
2013; Thudi, Li, Jackson, May, & Varshney, 2012; Wei, Bemmels, &
Fig. 1. Schematic illustration of techniques of genetic modiﬁcation challenging the molecular characterisation and/or identiﬁcation of the resulting GM plants. 1.a.
Transgenic GMP obtained by recombinant DNA techniques resulting in plant genomes (white bars) with one or several foreign DNA-inserts (black bars) with their respective
junctions. A junction is a novel chimeric region encompassing one of the borders of the DNA-insert and the adjacent native genomic DNA sequence. 1.b. GMP containing stacked
transformation events obtained by conventional crossing of lines obtained by 1.a. and resulting in plant genomes with different foreign DNA-inserts (black bar and red bar). Several
junctions need to be characterised.2. RNAi-based GMP, designed to induce silencing through RNA interference. This can be obtained by the insertion of a cassette bearing the sense
and anti-sense DNA (shaded bars) gene to be silenced.3. Cisgenic plants: DNA-inserts originates from the same or crossable species. The inserted DNA (grey bar) may have sequence
similarities with the endogenous sequences of the parental organism.4. GMP obtained by SDN-1, SDN-2 or ODM. SDN-1 and SDN-2 are two methods using site-directed nucleases
(SDN) generating site-speciﬁc double strand breaks. Double strand breaks are repaired either by non-homologous end-joining (SDN-1) or by homologous recombination (SDN-2).
Oligonucleotide mediated mutagenesis (ODM) uses chemically synthetized oligonucleotides to induce speciﬁc mutations at the target sequence. For SDN-1, SDN-2 or ODM the site
speciﬁc mutations consists of changes of single or few base pairs, short deletions or insertions (indel) which are not distinguishable from naturally occurring plants. No identi-
ﬁcation of junction proper to the genetically modiﬁed plants are possible. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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increased read length enables the assembly of larger contigs. This is
especially crucial when conducting de novo sequencing. High
coverage libraries with larger DNA-fragment sizes, combined with
paired-end sequencing protocols and the use of NGS platform
producing longer read lengths will result in less fragmented as-
semblies and larger contigs. Although NGS technologies allowing
longer read lengths (1e30 kb) exist, these are currently associated
with increased error rates which hamper accurate sequencing
(Quail et al., 2012). Therefore, with the objective to obtain accurate
sequence information of the inserted sequences (often >10 kbp),
NGS approaches for molecular characterisation of GMP are still
associated with Sanger sequencing for veriﬁcation and validation,
until further progress is made by the NGS platforms in delivering
longer and accurate read lengths. Eventually, increased read
lengths will also facilitate the capture approach elaborated above,
by extending the sequence reads of the ﬂanking regions present in
the captured fragments. Additionally, longer read lengths can solve
alignment problems associated with repetitive regions which often
occur in plant genomes (Liang et al., 2014). There is a need for
appropriate assembly tools for GMP since current assembly pro-
grams will automatically discard highly repetitive regions. So, un-
less sequence reads are sufﬁciently long to extend over the
repetitive regions, transforming DNA inserted in a highly repetitive
region will not easily be detected.
Besides repetitive regions, some other parts of the genome seem
also more difﬁcult to cover. This can be deduced from the obser-
vation that there is always an unpredictable part of the genome
missing in the NGS data. This is another technical limitation for the
assembly of the NGS reads. Lack of full genome accessibility may be
due to GC-rich regions (Sims et al., 2014) or to heterochromatin
structures, which could also hamper effective restrictionendonuclease digestion of the DNA, and hence also the detection of
the corresponding fragments by SB analysis.
With parameters such as the coverage or ‘average sequencing
depth’ (Sims et al., 2014), NGS allows for a quantiﬁcation of genome
accessibility. However, even if this parameter becomes quantiﬁable,
it remains questionable what minimal coverage should be required
to comprehensively cover the genomes. For the NGS approach, the
higher the coverage, the higher the associated cost, but a sufﬁ-
ciently high coverage is needed to allow for proper quality data
analysis (Kovalic et al., 2012; Sims et al., 2014). Therefore a balance
or trade-off between coverage and cost of analysis should be made,
and this might still be a technical limitation for read assembly.With
respect to the IR requirements, the question is raised concerning
the minimal required coverage for assessing the presence of all
detectable inserts, the absence of backbone sequences or the
modiﬁcation of a limited number of base pairs in a genome. Tar-
geted sequencing, using the appropriate probes, might overcome
this challenge, by reserving the generated reads to the fragments
that hybridized to the probes, thereby increasing the coverage of
the regions of interest.
Theoretically all single nucleotide polymorphisms (SNPs), in-
sertions, deletions that are present in the genome and which are
inferior to the length of the reads are retrievable whenmapping the
reads of a sample with an appropriate reference genome. The use of
this reference genome is an additional limitation for the assembly
and subsequent data analysis. In practice, accurate and complete
data will depend on the quality, availability and the choice of the
reference genome, including for those with highly repetitive se-
quences. Here the plasticity of crop genomes should be taken into
account as it leads to genomic diversity (Weber et al., 2012). This
will impact the appropriateness of the chosen reference genome
and hence the quality of the data analysis. Also in the advent of the
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mutagenesis (Fig. 1) the choice of the genome of reference will
also determine the outcome of the data. However, irrespective of
the technical feasibility of NGS, deliberately introduced SNPs will
hardly be distinguishable from naturally occurring variation that
may occur during the breeding process.
For cisgenesis, which is another upcoming plant breeding
technique consisting in introducing a gene (cisgene) from a cross-
able sexually compatible organism (same species or closely related
species), the reassembling approach of NGS will be challenging.
Indeed, in cisgenic plants the inserted gene includes its native
promoter and terminator originating from the same or a closely
related species and shows sequence identity or similarity to
endogenous sequences of the recipient genome. Therefore, the use
of the transforming DNA as a query sequence may be problematic.
So, unless a full genome assembly can be obtained, the cisgene
could be difﬁcult to detect using NGS. However, while NGS could
still offer a possibility for this issue in the future, the molecular
characterisation of cisgenic plants by the traditional SB approach
will remain fastidious.
Another bottleneck in the use of NGS for molecular characteri-
sation of GMP is that the digital nature of NGS also has a profound
impact on the data analysis and interpretation, accessibility, stor-
age, interpretation and visualization (Nekrutenko & Taylor, 2012),
both for the companies entering the dossier as for the risk asses-
sors. While the analysis of data obtained by means of SB analysis
deals with imaging issues and issues associated to image inter-
pretation, the application of NGS technologies is computationally
demanding. The substantial amount of raw data generated implies
the need for large data storage capacity, appropriate tools for al-
gorithms, computational infrastructure including high perfor-
mance computing and bioinformatics skills. Also, to further
optimize the data analysis, speciﬁc bioinformatics tools need to be
developed, such as dedicated assembler tools for GMP NGS data,
taking into account the current bottlenecks inherent to the type of
material to be sequenced, as described above (Liang et al., 2014). In
addition, the use of different analysis programmes or parameters to
handle the amount of NGS generated data can lead to different
conclusions on the molecular characterisation. This makes the set-
up of criteria to retrieve and present relevant and interpretable data
of good quality both important and challenging. Clarity on the
parameters used for data analysis will enhance transparency and
improve reliability of subsequent evaluations. This can be obtained
by access to primary data, information on the reference genome in
case of read mapping, knowledge of the used software for data
analysis and insights in the choice of data visualisation including
quality-values (Q-values) for each of the bases determined
(Nekrutenko & Taylor, 2012).
5. Will advanced information at the nucleic acid level, offered
by NGS, contribute to the RA of GMP?
As elaborated in Table 1 column 3, NGS will cover all data re-
quirements for RA at least to the same extent as the currently used
techniques (column 2). Even more, NGS could potentially detect
unintended insertions or modiﬁcations that due to their small size
are not revealed by SB (Yang et al., 2013). Irrespective of the fact
that NGS may reveal this information, and clearly extends those in
amount currently obtained by SB and Sanger sequencing, it should
be questioned whether this extended information at the nucleic
acid level would actually contribute to RA. One of the current de-
bates with regard to the molecular characterisation of GMP, irre-
spective whether this was done by NGS, is to what extent the
unintended presence of small inserts in the plant genome as a
result of the transformation needs to be identiﬁed andcharacterised taking into account that unintended effects are for
GMP also assessed on the basis of agronomic, phenotypic and
compositional properties. Depending on the biology of the plant
species and on genetic linkage, such small inserts may be separated
from the functional insert by genetic segregation in the progeny of
the primary transformant. As a consequence, where the trans-
formation event is introduced into different genetic backgrounds
by conventional breeding, the small inserts may not be present
anymore in the plant material placed on the market. Additionally,
unintended effects also arise from conventional breeding through
molecular mechanisms that naturally occur in plants (Ossowski
et al., 2010; Schnell et al., 2015; Vaughn & Bennetzen, 2014). Un-
desirable phenotypes are removed during selection and breeding
programs and no such risk/safety assessments with molecular
characterisation requirements are asked for plants obtained by
conventional breeding. It has to be remarked that the assessment of
unintended effects might be different for GM animals, as no doc-
uments describing which agronomic, phenotypic and composi-
tional data are needed for the risk assessment of GM animals, are
yet available.
It is also possible that NGS could present an added value with
regard to data required for GMP with stacked events since the re-
sequencing of the stacked DNA-inserts and their ﬂanking regions
is required to assess their integrity (Implementing Regulation and
Table 1, vii). However, GMP with stacked events usually have been
produced by conventional crossing of parental GMP with one or
more single events, for which the insert DNA has been sequenced,
and do not involve additional genetic transformation. Moreover,
safety assessment evaluations so far, based on SB analysis, did not
reveal the concern that insert integrity would be more compro-
mised during conventional crossing of two GM lines compared to
crossing of a GM line with a conventional line (Kok et al., 2014;
Waigmann, Gomes, Lanzoni, & Perry, 2013).
6. Conclusions and recommendations
Despite practical and economic reasons and the rapid evolution
in NGS technologies, it is difﬁcult to predict at which pace NGS-
generated data will be presented in regulatory dossiers for RA.
Contrary to SB where for each GM crop characterisation, speciﬁc
probes (sometime radioactively labelled) need to be developed,
NGS is a universal, high-throughput platform for generating data.
The more GMP are characterised the higher the beneﬁt of its
streamlined procedures and its relative cost-effectiveness will
become.
It remains an open question to which extent RA ofﬁces should
repeat the data analysis performed by the applicants to verify the
accurateness, reproducibility and quality of the data presented in
the regulatory dossier. Should this be necessary, it is also not clear
whether risk evaluators should repeat the data analysis only by
using algorithms proposed by the applicant or by using algorithms
which have been identiﬁed as appropriate and of sufﬁcient quality
by RA ofﬁces themselves. The latter would imply RA ofﬁces to have
their own trained bioinformaticians and implementing specialized
data analysis platforms.
Deﬁning best practices and standardization of bioinformatics
tools could facilitate the set-up of a common workﬂow to be fol-
lowed by applicants for presenting NGS data for the molecular
characterisation of GMP. This would allow RA ofﬁces to assess the
presentation of data according to a streamlined approach and, if
necessary, to focus efforts on developing expertise in certain
anticipated data algorithms. The set-up of such a workﬂow would
most likely include issues such as sample/library preparation, NGS
platform to be used, required read length to generate, coverage to
be used and to be demonstrated to determine the detection limit,
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use of appropriate data analysis algorithms. Moreover, future
possible initiatives for deﬁning such workﬂow should also take into
account the expertise that is currently developed with research
projects exploring the feasibility of using NGS for the detection and
identiﬁcation of GMP.
While a common workﬂow could assist applicants willing to
integrate NGS-generated data in their applications, it should be
kept in mind that the implementation of NGS technologies are
currently not affordable to all potential applicants willing to release
a product into the environment. Despite vast decreases in recent
years, costs remain substantial. Therefore, risk assessors should pay
attention not to request data just because NGS may offer the
technical possibilities to do so. Instead, it will be important to focus
on (NGS) data that actually fuel the RA.
We identiﬁed two developments in plant breeding that could
further pave the way for implementing NGS technologies in the
preparation and presentation of data for regulatory approval.
Firstly, for novel plant breeding products resulting in small modi-
ﬁcations, NGS-data generated by the whole genome approach may
soon reveal more precise information with respect to the presence
of small changes at the nucleic acid level. Secondly, for stacked
events, the requirement to re-sequence inserts and ﬂanking regions
may also favour high-throughput technologies that can generate
data with relative increasing cost-effectiveness and feasibility.
We conclude that although NGS might present clear advantages
for product developers as a method at least as well performing as
SB, while being faster and more efﬁcient, NGS currently does not
always offer a signiﬁcant added value with respect to the RA of
GMPs. Despite some advantages, NGS has currently not the po-
tential to rule out SB and Sanger sequencing for the molecular
characterisation of GMP. However, the approaches used so far may
soon be further challenged by the fast evolution in NGS technolo-
gies and also by the recent developments in molecular breeding of
plants, e.g. increasing number of stacked events, expanding variety
of transformed species and new traits, and new techniques for
genetic modiﬁcation of crop plants. We therefore plead for a set-up
of criteria for the generation of relevant and interpretable NGS data
for RA to ensure that data are generated, presented and analysed in
a way that facilitates a scientiﬁcally sound assessment. This should
be done in the ﬁrst place for GMP, as they constitute the vast ma-
jority of GM applications for food and feed uses. However, similar
initiatives could be taken for the RA of GMmicroorganisms and GM
animals, as part of the issues discussed in this viewpoint apply to
these GMO as well. Recommendations on which and in what way
these data should be presented will be beneﬁcial for both appli-
cants in view of the preparation of regulatory dossiers and risk
evaluators.
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